-
1
-
-
34248994895
-
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor
-
Spisani S, Fraulini A, Varani K, Falzarano S, Cavicchioni G. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor. Eur. J. Pharmacol. 2007; 567: 171-176.
-
(2007)
Eur. J. Pharmacol.
, vol.567
, pp. 171-176
-
-
Spisani, S.1
Fraulini, A.2
Varani, K.3
Falzarano, S.4
Cavicchioni, G.5
-
2
-
-
27144511213
-
Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban
-
Manning M, Cheng LL, Stoev S, Wo NC, Chan WY, Szeto HH, Durroux T, Mouillac B, Barberis C. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. J. Pept. Sci. 2005; 11: 593-608.
-
(2005)
J. Pept. Sci.
, vol.11
, pp. 593-608
-
-
Manning, M.1
Cheng, L.L.2
Stoev, S.3
Wo, N.C.4
Chan, W.Y.5
Szeto, H.H.6
Durroux, T.7
Mouillac, B.8
Barberis, C.9
-
3
-
-
25644444563
-
Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors
-
Igarashi H, Ito T, Mantey SA, Pradhan TK, Hou W, Coy DH, Jensen RT. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors. J. Pharmacol. Exp. Ther. 2005; 315: 370-381.
-
(2005)
J. Pharmacol. Exp. Ther.
, vol.315
, pp. 370-381
-
-
Igarashi, H.1
Ito, T.2
Mantey, S.A.3
Pradhan, T.K.4
Hou, W.5
Coy, D.H.6
Jensen, R.T.7
-
4
-
-
34547662365
-
Comparison of opioid receptor binding in horse, guinea pig, and rat cerebral cortex and cerebellum
-
Thomasy SM, Moeller BC, Stanley SD. Comparison of opioid receptor binding in horse, guinea pig, and rat cerebral cortex and cerebellum. Vet. Anaesth. Analg. 2007; 34: 351-358.
-
(2007)
Vet. Anaesth. Analg.
, vol.34
, pp. 351-358
-
-
Thomasy, S.M.1
Moeller, B.C.2
Stanley, S.D.3
-
5
-
-
77952320541
-
Mutagenesis studies of neuropeptide S identify a suitable peptide tracer for neuropeptide S receptor binding studies and peptides selectively activating the I107 variant of human neuropeptide S receptor
-
Nepomuceno D, Sutton S, Yu J, Zhu J, Liu C, Lovenberg T, Bonaventure P. Mutagenesis studies of neuropeptide S identify a suitable peptide tracer for neuropeptide S receptor binding studies and peptides selectively activating the I107 variant of human neuropeptide S receptor. Eur. J. Pharmacol. 2010; 635: 27-33.
-
(2010)
Eur. J. Pharmacol.
, vol.635
, pp. 27-33
-
-
Nepomuceno, D.1
Sutton, S.2
Yu, J.3
Zhu, J.4
Liu, C.5
Lovenberg, T.6
Bonaventure, P.7
-
6
-
-
0344269350
-
Interaction of agonist peptide [3H]Tyr-Ala-Phe-Phe-NH2 with [mu]-opioid receptor in rat brain and CHO-[mu]/1 cell line
-
Spetea M, Ötvös F, Tóth G, Nguyen TMD, Schiller PW, Vogel Z, Borsodi A. Interaction of agonist peptide [3H]Tyr-Ala-Phe-Phe-NH2 with [mu]-opioid receptor in rat brain and CHO-[mu]/1 cell line. Peptides 1998; 19: 1091-1098.
-
(1998)
Peptides
, vol.19
, pp. 1091-1098
-
-
Spetea, M.1
Ötvös, F.2
Tóth, G.3
Nguyen, T.M.D.4
Schiller, P.W.5
Vogel, Z.6
Borsodi, A.7
-
7
-
-
0035937529
-
Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS)
-
Vonhof S, Barone FC, Price WJ, Paakkari P, Millison JH, Feuerstein GZ, Siren ALK. Receptor binding and biological activity of the dermorphin analog Tyr-D-Arg(2)-Phe-Sar (TAPS). Eur. J. Pharmacol. 2001; 416: 83-93.
-
(2001)
Eur. J. Pharmacol.
, vol.416
, pp. 83-93
-
-
Vonhof, S.1
Barone, F.C.2
Price, W.J.3
Paakkari, P.4
Millison, J.H.5
Feuerstein, G.Z.6
Siren, A.L.K.7
-
8
-
-
1542466530
-
The chemistry of the opioid receptor binding sites
-
Medzihradszky K. The chemistry of the opioid receptor binding sites. J. Pept. Sci. 2003; 9: 333-353.
-
(2003)
J. Pept. Sci.
, vol.9
, pp. 333-353
-
-
Medzihradszky, K.1
-
9
-
-
0035292828
-
Delivery of peptides and proteins through the blood-brain barrier
-
Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Delivery Rev. 2001; 46: 247-279.
-
(2001)
Adv. Drug Delivery Rev.
, vol.46
, pp. 247-279
-
-
Bickel, U.1
Yoshikawa, T.2
Pardridge, W.M.3
-
11
-
-
0033932502
-
Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier
-
Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J. Pharmacol. Exp. Ther. 2000; 294: 73-79.
-
(2000)
J. Pharmacol. Exp. Ther.
, vol.294
, pp. 73-79
-
-
Gao, B.1
Hagenbuch, B.2
Kullak-Ublick, G.A.3
Benke, D.4
Aguzzi, A.5
Meier, P.J.6
-
12
-
-
0030996655
-
Peptide delivery into the central nervous system: Invasive, physiological and chemical approaches
-
Prokai L. Peptide delivery into the central nervous system: Invasive, physiological and chemical approaches. Expert Opin. Ther. Pat. 1997; 7: 233-245.
-
(1997)
Expert Opin. Ther. Pat.
, vol.7
, pp. 233-245
-
-
Prokai, L.1
-
13
-
-
70449529433
-
Structure and function of the blood-brain barrier
-
Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010; 37: 13-25.
-
(2010)
Neurobiol. Dis.
, vol.37
, pp. 13-25
-
-
Abbott, N.J.1
Patabendige, A.A.K.2
Dolman, D.E.M.3
Yusof, S.R.4
Begley, D.J.5
-
14
-
-
0033973460
-
Tight junctions of the blood-brain barrier
-
Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 2000; 20: 57-76.
-
(2000)
Cell. Mol. Neurobiol.
, vol.20
, pp. 57-76
-
-
Kniesel, U.1
Wolburg, H.2
-
15
-
-
33645420927
-
Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin
-
Pan WH, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 2006; 27: 911-916.
-
(2006)
Peptides
, vol.27
, pp. 911-916
-
-
Pan, W.H.1
Tu, H.2
Kastin, A.J.3
-
16
-
-
0021287899
-
Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism
-
Banks WA, Kastin AJ, Coy DH. Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism. Brain Res. 1984; 301: 201-207.
-
(1984)
Brain Res.
, vol.301
, pp. 201-207
-
-
Banks, W.A.1
Kastin, A.J.2
Coy, D.H.3
-
17
-
-
0036842080
-
Radiolabeled peptides in the diagnosis and therapy of oncological diseases
-
Weiner RE, Thakur ML. Radiolabeled peptides in the diagnosis and therapy of oncological diseases. Appl. Radiat. Isot. 2002; 57: 749-763.
-
(2002)
Appl. Radiat. Isot.
, vol.57
, pp. 749-763
-
-
Weiner, R.E.1
Thakur, M.L.2
-
18
-
-
33750932324
-
Synthesis, radiolabeling and receptor binding of [H-3][(1S,2R)ACPC(2)]endomorphin-2
-
Keresztes A, Toth G, Fulop F, Szucs M. Synthesis, radiolabeling and receptor binding of [H-3][(1S, 2R)ACPC(2)]endomorphin-2. Peptides 2006; 27: 3315-3321.
-
(2006)
Peptides
, vol.27
, pp. 3315-3321
-
-
Keresztes, A.1
Toth, G.2
Fulop, F.3
Szucs, M.4
-
20
-
-
0036786475
-
Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II
-
Hau VS, Huber JD, Campos CR, Lipkowski AW, Misicka A, Davis TP. Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. J. Pharm. Sci. 2002; 91: 2140-2149.
-
(2002)
J. Pharm. Sci.
, vol.91
, pp. 2140-2149
-
-
Hau, V.S.1
Huber, J.D.2
Campos, C.R.3
Lipkowski, A.W.4
Misicka, A.5
Davis, T.P.6
-
21
-
-
40749114326
-
Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability
-
Dangoor D, Biondi B, Gobbo M, Vachutinski Y, Fridkin M, Gozes I, Rocchi R. Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability. J. Pept. Sci. 2008; 14: 321-328.
-
(2008)
J. Pept. Sci.
, vol.14
, pp. 321-328
-
-
Dangoor, D.1
Biondi, B.2
Gobbo, M.3
Vachutinski, Y.4
Fridkin, M.5
Gozes, I.6
Rocchi, R.7
-
22
-
-
0035047501
-
In vitro metabolism of opioid tetrapeptide agonists in various tissues and subcellular fractions from rats
-
Krondahl E, von Euler-Chelpin H, Orzechowski A, Ekström G, Lennernäs H. In vitro metabolism of opioid tetrapeptide agonists in various tissues and subcellular fractions from rats. Peptides 2001; 22: 613-621.
-
(2001)
Peptides
, vol.22
, pp. 613-621
-
-
Krondahl, E.1
von Euler-Chelpin, H.2
Orzechowski, A.3
Ekström, G.4
Lennernäs, H.5
-
23
-
-
2142658722
-
New trends in the development of opioid peptide analogues as advanced remedies for pain relief
-
Gentilucci L. New trends in the development of opioid peptide analogues as advanced remedies for pain relief. Curr. Top. Med. Chem. 2004; 4: 19-38.
-
(2004)
Curr. Top. Med. Chem.
, vol.4
, pp. 19-38
-
-
Gentilucci, L.1
-
24
-
-
33947203944
-
Novel glycosylated (LyS(7))-dermorphin analogues: synthesis, biological activity and conformational investigations
-
Biondi L, Filira F, Giannini E, Gobbo M, Lattanzi R, Negri L, Rocchi R. Novel glycosylated (LyS(7))-dermorphin analogues: synthesis, biological activity and conformational investigations. J. Pept. Sci. 2007; 13: 179-189.
-
(2007)
J. Pept. Sci.
, vol.13
, pp. 179-189
-
-
Biondi, L.1
Filira, F.2
Giannini, E.3
Gobbo, M.4
Lattanzi, R.5
Negri, L.6
Rocchi, R.7
-
25
-
-
33846661753
-
Synthesis and biological activity of homoarginine-containing opioid peptides
-
Izdebski J, Kunce D, Schiller PW, Chung NN, Gers T, Zelman M, Grabek M. Synthesis and biological activity of homoarginine-containing opioid peptides. J. Pept. Sci. 2007; 13: 27-30.
-
(2007)
J. Pept. Sci.
, vol.13
, pp. 27-30
-
-
Izdebski, J.1
Kunce, D.2
Schiller, P.W.3
Chung, N.N.4
Gers, T.5
Zelman, M.6
Grabek, M.7
-
26
-
-
77952544460
-
In vitro human brain methionine-enkephalin metabolism
-
Mosnaim AD, Puente J, Tse R, Wolf ME. In vitro human brain methionine-enkephalin metabolism. FASEB J. 2005; 19: A509-A509.
-
(2005)
FASEB J.
, vol.19
-
-
Mosnaim, A.D.1
Puente, J.2
Tse, R.3
Wolf, M.E.4
-
27
-
-
52049107373
-
In vitro metabolic stability of obestatin: kinetics and identification of cleavage products
-
Vergote V, Van Dorpe S, Peremans K, Burvenich C, De Spiegeleer B. In vitro metabolic stability of obestatin: kinetics and identification of cleavage products. Peptides 2008; 29: 1740-1748.
-
(2008)
Peptides
, vol.29
, pp. 1740-1748
-
-
Vergote, V.1
Van Dorpe, S.2
Peremans, K.3
Burvenich, C.4
De Spiegeleer, B.5
-
28
-
-
77952545323
-
Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides
-
Van Dorpe S, Adriaens A, Polis I, Peremans K, Van Bocxlaer J, De Spiegeleer B. Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides. Peptides 2010; 31: 1390-1399.
-
(2010)
Peptides
, vol.31
, pp. 1390-1399
-
-
Van Dorpe, S.1
Adriaens, A.2
Polis, I.3
Peremans, K.4
Van Bocxlaer, J.5
De Spiegeleer, B.6
-
29
-
-
0025772704
-
Multiple-criteria optimization
-
Deming SN. Multiple-criteria optimization. J. Chromatogr. 1991; 550: 15-25.
-
(1991)
J. Chromatogr.
, vol.550
, pp. 15-25
-
-
Deming, S.N.1
-
30
-
-
0000432952
-
Simultaneous-optimization of several response variables
-
Derringer G, Suich R. Simultaneous-optimization of several response variables. J. Qual. Technol. 1980; 12: 214-219.
-
(1980)
J. Qual. Technol.
, vol.12
, pp. 214-219
-
-
Derringer, G.1
Suich, R.2
-
31
-
-
77950841392
-
Hydrophilic interaction LC of peptides: columns comparison and clustering
-
Van Dorpe S, Vergote V, Pezeshki A, Burvenich C, Peremans K, De Spiegeleer B. Hydrophilic interaction LC of peptides: columns comparison and clustering. J. Sep. Sci. 2010; 33: 728-739.
-
(2010)
J. Sep. Sci.
, vol.33
, pp. 728-739
-
-
Van Dorpe, S.1
Vergote, V.2
Pezeshki, A.3
Burvenich, C.4
Peremans, K.5
De Spiegeleer, B.6
-
32
-
-
77954814751
-
Evolving molecules using multi-objective optimization: applying to ADME/Tox
-
Ekins S, Honeycutt JD, Metz JT. Evolving molecules using multi-objective optimization: applying to ADME/Tox. Drug Discov. Today 2010; 15: 451-460.
-
(2010)
Drug Discov. Today
, vol.15
, pp. 451-460
-
-
Ekins, S.1
Honeycutt, J.D.2
Metz, J.T.3
-
33
-
-
41849122633
-
Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: the obestatin case
-
De Spiegeleer B, Vergote V, Pezeshki A, Peremans K, Burvenich C. Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: the obestatin case. Anal. Biochem. 2008; 376: 229-234.
-
(2008)
Anal. Biochem.
, vol.376
, pp. 229-234
-
-
De Spiegeleer, B.1
Vergote, V.2
Pezeshki, A.3
Peremans, K.4
Burvenich, C.5
-
34
-
-
30444452836
-
On the rounding rules for logarithmic and exponential operations
-
Chen WD, Lee W, Mulliss CL. On the rounding rules for logarithmic and exponential operations. Chin. J. Phys. 2005; 43: 1017-1034.
-
(2005)
Chin. J. Phys.
, vol.43
, pp. 1017-1034
-
-
Chen, W.D.1
Lee, W.2
Mulliss, C.L.3
-
35
-
-
20444480221
-
Simultaneous optimization of the resolution and analysis time in micellar liquid chromatography of phenyl thiohydantoin amino acids using Derringer's desirability function
-
Safa F, Hadjmohammadi MR. Simultaneous optimization of the resolution and analysis time in micellar liquid chromatography of phenyl thiohydantoin amino acids using Derringer's desirability function. J. Chromatogr., A 2005; 1078: 42-50.
-
(2005)
J. Chromatogr., A
, vol.1078
, pp. 42-50
-
-
Safa, F.1
Hadjmohammadi, M.R.2
-
36
-
-
0002410331
-
A balancing act-optimizing a product's properties
-
Derringer GC. A balancing act-optimizing a product's properties. Qual. Prog. 1994; 27: 51-58.
-
(1994)
Qual. Prog.
, vol.27
, pp. 51-58
-
-
Derringer, G.C.1
-
37
-
-
70849130984
-
Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action
-
Aldrich JV, Patkar KA, McLaughlin JP. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. Proc. Natl. Acad. Sci. U.S.A. 2009; 106: 18396-18401.
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 18396-18401
-
-
Aldrich, J.V.1
Patkar, K.A.2
McLaughlin, J.P.3
-
38
-
-
40249111499
-
[Dmt(1), D-1-Nal(3)]morphiceptin, a novel opioid peptide analog with high analgesic activity
-
Fichna J, Do-Rego JC, Chung NN, Costentin J, Schiller PW, Janecka A. [Dmt(1), D-1-Nal(3)]morphiceptin, a novel opioid peptide analog with high analgesic activity. Peptides 2008; 29: 633-638.
-
(2008)
Peptides
, vol.29
, pp. 633-638
-
-
Fichna, J.1
Do-Rego, J.C.2
Chung, N.N.3
Costentin, J.4
Schiller, P.W.5
Janecka, A.6
-
39
-
-
77950190490
-
Development of opioid peptide analogs for pain relief
-
Janecka A, Perlikowska R, Gach K, Wyrebska A, Fichna J. Development of opioid peptide analogs for pain relief. Curr. Pharm. Des. 2010; 16: 1126-1135.
-
(2010)
Curr. Pharm. Des.
, vol.16
, pp. 1126-1135
-
-
Janecka, A.1
Perlikowska, R.2
Gach, K.3
Wyrebska, A.4
Fichna, J.5
-
40
-
-
70549106508
-
Synthesis and pharmacological properties of a new fluorescent opioid peptide analog
-
Lukowiak M, Kosson P, Hennink WE, Lipikowski AW. Synthesis and pharmacological properties of a new fluorescent opioid peptide analog. Pharmacol. Rep. 2009; 61: 727-731.
-
(2009)
Pharmacol. Rep.
, vol.61
, pp. 727-731
-
-
Lukowiak, M.1
Kosson, P.2
Hennink, W.E.3
Lipikowski, A.W.4
|